Abstract:Abstract Introduction/Objective Introduction: Numerous studies have highlighted the diverse biochemical and pharmacological properties of berberine (BER), including its anti-inflammatory, antioxidant, anticancer, and hypolipidemic effects. Nanoparticles play a crucial role in enhancing drug delivery by providing a larger surface area, facilitating quicker dissolution in the bloodstream. Methods/Case Report Methods: Blank bovine serum albumin nanoparticles (BSA NPs) were prepared using a desolvation process, followed by the fabrication of berberine-loaded BSA nanoparticles (BER-NP). Physicochemical characterization, including particle size and zeta potential, was conducted using a Malvern Zetasizer. The mean particle size and distribution were determined using photon correlation spectroscopy (PCS), and transmission electron microscope (TEM) images were obtained for visualization. Fourier transform infrared (FTIR) spectra and differential scanning calorimetry (DSC) thermograms were recorded to assess drug encapsulation efficiency (EE). Berberine release from BER-NPs was evaluated using dialysis membranes. Results (if a Case Study enter NA) Results: FTIR spectra and DSC thermograms confirmed successful drug loading into the nanoparticles. Encapsulation efficiency was determined by UV absorption spectroscopy, revealing high efficiency in the encapsulation process. Dialysis membranes demonstrated controlled release kinetics of berberine from BER-NPs, indicating their potential for targeted drug delivery. Conclusion Conclusion: Berberine-loaded bovine serum albumin nanoparticles exhibit favorable characteristics for drug delivery applications, including enhanced permeation across biological barriers. These nanoparticles hold promise for targeted therapy and combination drug regimens, offering potential benefits for various medical interventions.

Preparation and Characterization of Galactosylated Bovine Serum Albumin Nanoparticles for Liver-Targeted Delivery of Oridonin.

Galactosylated bovine serum albumin nanoparticles for parenteral delivery of oridonin: tissue distribution and pharmacokinetic studies.

Galactosylated Chitosan Nanoparticles for Hepatocyte-Targeted Delivery of Oridonin

Novel Galactosylated Biodegradable Nanoparticles for Hepatocyte-Delivery of Oridonin

In Vitro and in Vivo Studies of Galactose-Modified Liver-Targeting Liposomes.

Studies on the Oridonin-Loaded Poly(d,l-Lactic Acid) Nanoparticles in Vitro and in Vivo

Preparation and Characterization of Sodium Ferulate Entrapped Bovine Serum Albumin Nanoparticles for Liver Targeting

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

In Vivo Studies On The Oridonin-Loaded Nanostructured Lipid Carriers

Preparation and Characterization of Oridonin-loaded Poly (caprolactone)-Poly (ethylene oxide)-Poly (caprolactone) Copolymer Nanoparticles

Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.

Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo

[Preparation of bovine serum albumin nanoparticles surface-modified with glycyrrhizin].

Preparation, Characterization, and in Vitro/vivo Studies of Oleanolic Acid-Loaded Lactoferrin Nanoparticles

Preparation And Characteristics Of Oridonin-Loaded Nanostructured Lipid Carriers As A Controlled-Release Delivery System

Preparation and Evaluation of Galactosyl Adriamycin BSA Nanoparticles

Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.

Preparation and characteristics of LY294002-1oaded albumin nanoparticles for intravenous injection

Albumin-bioinspired Iridium Oxide Nanoplatform with High Photothermal Conversion Efficiency for Synergistic Chemo-Photothermal of Osteosarcoma

Berberine-Loaded Bovine Serum Albumin Nanoparticles: Fabrication, Characterization, and Drug Release Evaluation

In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.